Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Jul;3(4):429–431. doi: 10.1128/cdli.3.4.429-431.1996

Lack of agreement among two commercial enzyme-linked immunosorbent antibody assays and a conventional immunofluorescence-based method for detecting islet cell autoantibodies.

E J Baron 1, D E Weber 1, L G Weide 1
PMCID: PMC170362  PMID: 8807208

Abstract

Two commercial enzyme-linked immunosorbent assays (ELISAs) for antibodies associated with development of insulin-dependent (type 1) diabetes mellitus (IDDM) were evaluated in conjunction with a conventional indirect immunofluorescent-antibody-islet cell antibody (ICA) test and a radioimmunoprecipitation method for detection of insulin autoantibodies in sera from a selected group of patients. The anti-ICA ELISA was positive for only 1 to 17 serum samples from newly diagnosed IDDM patients but yielded false-positive results with 2 of 6 serum samples containing non-diabetes-related autoantibodies. Although the anti-glutamic acid decarboxylase ELISA did not show positive results for sera with other autoantibodies, it was positive for only 4 of 29 serum samples from recently diagnosed IDDM patients and for 49% of 37 indirect immunofluorescent-antibody-ICA test-positive sera. Until the antibodies associated with the development of diabetes are better characterized, allowing better standards for comparison, it will be difficult to evaluate commercial assays in this field.

Full Text

The Full Text of this article is available as a PDF (186.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson M. A., Kaufman D. L., Newman D., Tobin A. J., Maclaren N. K. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest. 1993 Jan;91(1):350–356. doi: 10.1172/JCI116192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson M. A., Maclaren N. K., Scharp D. W., Lacy P. E., Riley W. J. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet. 1990 Jun 9;335(8702):1357–1360. doi: 10.1016/0140-6736(90)91241-2. [DOI] [PubMed] [Google Scholar]
  3. Bingley P. J., Bonifacio E., Gale E. A. Can we really predict IDDM? Diabetes. 1993 Feb;42(2):213–220. doi: 10.2337/diab.42.2.213. [DOI] [PubMed] [Google Scholar]
  4. DeAizpurua H. J., Harrison L. C., Cram D. S. An ELISA for antibodies to recombinant glutamic acid decarboxylase in IDDM. Diabetes. 1992 Sep;41(9):1182–1187. doi: 10.2337/diab.41.9.1182. [DOI] [PubMed] [Google Scholar]
  5. Genovese S., Bonifacio E., McNally J. M., Dean B. M., Wagner R., Bosi E., Gale E. A., Bottazzo G. F. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992 Apr;35(4):385–388. doi: 10.1007/BF00401207. [DOI] [PubMed] [Google Scholar]
  6. Gianani R., Pugliese A., Bonner-Weir S., Shiffrin A. J., Soeldner J. S., Erlich H., Awdeh Z., Alper C. A., Jackson R. A., Eisenbarth G. S. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes. 1992 Mar;41(3):347–353. doi: 10.2337/diab.41.3.347. [DOI] [PubMed] [Google Scholar]
  7. Gleichmann H., Bottazzo G. F. Progress toward standardization of cytoplasmic islet cell-antibody assay. Diabetes. 1987 May;36(5):578–584. doi: 10.2337/diab.36.5.578. [DOI] [PubMed] [Google Scholar]
  8. Gorsuch A. N., Spencer K. M., Lister J., McNally J. M., Dean B. M., Bottazzo G. F., Cudworth A. G. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet. 1981 Dec 19;2(8260-61):1363–1365. doi: 10.1016/s0140-6736(81)92795-1. [DOI] [PubMed] [Google Scholar]
  9. Greenbaum C. J., Palmer J. P., Kuglin B., Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab. 1992 May;74(5):1040–1044. doi: 10.1210/jcem.74.5.1569152. [DOI] [PubMed] [Google Scholar]
  10. Greenbaum C. J., Palmer J. P., Nagataki S., Yamaguchi Y., Molenaar J. L., Van Beers W. A., MacLaren N. K., Lernmark A. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes. 1992 Dec;41(12):1570–1574. doi: 10.2337/diab.41.12.1570. [DOI] [PubMed] [Google Scholar]
  11. Hagopian W. A., Karlsen A. E., Gottsäter A., Landin-Olsson M., Grubin C. E., Sundkvist G., Petersen J. S., Boel E., Dyrberg T., Lernmark A. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest. 1993 Jan;91(1):368–374. doi: 10.1172/JCI116195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harrison L. C., Honeyman M. C., DeAizpurua H. J., Schmidli R. S., Colman P. G., Tait B. D., Cram D. S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 1993 May 29;341(8857):1365–1369. doi: 10.1016/0140-6736(93)90940-i. [DOI] [PubMed] [Google Scholar]
  13. Maclaren N., Schatz D., Drash A., Grave G. Initial pathogenic events in IDDM. Diabetes. 1989 Apr;38(4):534–538. doi: 10.2337/diab.38.4.534. [DOI] [PubMed] [Google Scholar]
  14. Mauch L., Seissler J., Haubruck H., Cook N. J., Abney C. C., Berthold H., Wirbelauer C., Liedvogel B., Scherbaum W. A., Northemann W. Baculovirus-mediated expression of human 65 kDa and 67 kDa glutamic acid decarboxylases in SF9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus. J Biochem. 1993 Jun;113(6):699–704. doi: 10.1093/oxfordjournals.jbchem.a124106. [DOI] [PubMed] [Google Scholar]
  15. Myers M. A., Rabin D. U., Rowley M. J. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes. 1995 Nov;44(11):1290–1295. doi: 10.2337/diab.44.11.1290. [DOI] [PubMed] [Google Scholar]
  16. Rabin D. U., Pleasic S. M., Shapiro J. A., Yoo-Warren H., Oles J., Hicks J. M., Goldstein D. E., Rae P. M. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol. 1994 Mar 15;152(6):3183–3188. [PubMed] [Google Scholar]
  17. Riley W. J. Insulin dependent diabetes mellitus, an autoimmune disorder? Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S92–S98. doi: 10.1016/0090-1229(89)90074-3. [DOI] [PubMed] [Google Scholar]
  18. Riley W. J., Maclaren N. K., Krischer J., Spillar R. P., Silverstein J. H., Schatz D. A., Schwartz S., Malone J., Shah S., Vadheim C. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med. 1990 Oct 25;323(17):1167–1172. doi: 10.1056/NEJM199010253231704. [DOI] [PubMed] [Google Scholar]
  19. Scherbaum W. A., Trischler G., Pfeiffer E. F. Non-human primate pancreas as a substrate for the detection of islet-cell antibodies in human sera. Diabetes Res Clin Pract. 1989 Jun 20;7(1):1–5. doi: 10.1016/0168-8227(89)90037-5. [DOI] [PubMed] [Google Scholar]
  20. Tuomi T., Groop L. C., Zimmet P. Z., Rowley M. J., Knowles W., Mackay I. R. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes. 1993 Feb;42(2):359–362. doi: 10.2337/diab.42.2.359. [DOI] [PubMed] [Google Scholar]
  21. Tuomilehto J., Zimmet P., Mackay I. R., Koskela P., Vidgren G., Toivanen L., Tuomilehto-Wolf E., Kohtamäki K., Stengård J., Rowley M. J. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet. 1994 Jun 4;343(8910):1383–1385. doi: 10.1016/s0140-6736(94)92521-6. [DOI] [PubMed] [Google Scholar]
  22. Velloso L. A., Kämpe O., Hallberg A., Christmanson L., Betsholtz C., Karlsson F. A. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest. 1993 May;91(5):2084–2090. doi: 10.1172/JCI116431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vives M., Somoza N., Soldevila G., Gomis R., Lucas A., Sanmarti A., Pujol-Borrell R. Reevaluation of autoantibodies to islet cell membrane in IDDM. Failure to detect islet cell surface antibodies using human islet cells as substrate. Diabetes. 1992 Dec;41(12):1624–1631. doi: 10.2337/diab.41.12.1624. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES